Petros Pharmaceuticals, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Petros Pharmaceuticals, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $5.99 million for the year ending 2022.

  • Petros Pharmaceuticals, Inc. showed a decrease of -23.3% in Revenue From Contract With Customer Excluding Assessed Tax from 2021 to 2022.
  • This data is from Petros Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2023.
  • XBRL data for this metric is available from 2020 to 2022 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2020 to 2022), Petros Pharmaceuticals, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 37.3%.
  • Historical annual values: Fiscal year 2022: $5.99 million | Fiscal year 2021: $7.81 million | Fiscal year 2020: $9.56 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: